Patent application number | Description | Published |
20080207900 | TWO CYCLIC OXOMORPHORIN DERIVATIVES - The present invention relates to a compound represented by formula (I): | 08-28-2008 |
20090062529 | MULTI-CYCLIC COMPOUNDS - A compound represented by the formula (I): | 03-05-2009 |
20090181945 | TWO CYCLIC CINNAMIDE COMPOUND - The present invention relates to a novel two cyclic cinnamide compound and a pharmaceutical agent comprising the compound as an active ingredient. The two cyclic cinnamide compound represented by the general formula (I): | 07-16-2009 |
20090203697 | HETEROCYCLIC TYPE CINNAMIDE DERIVATIVE - Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. | 08-13-2009 |
20090281310 | CINNAMIDE COMPOUND - The present invention relates to a process for preparing a compound of formula (6a): | 11-12-2009 |
20100105904 | UREA TYPE CINNAMIDE DERIVATIVE - Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. | 04-29-2010 |
20100113773 | BICYCLIC OXOMORPHOLINE DERIVATIVE - The present invention relates to a compound represented by formula (I): | 05-06-2010 |
20100168095 | MULTI-CYCLIC CINNAMIDE DERIVATIVES - The present invention provides a compound represented by the formula (I): | 07-01-2010 |
20110009619 | POLYCYCLIC COMPOUND - Disclosed is a compound represented by the formula (I): | 01-13-2011 |
20110065696 | IMIDAZOYL PYRIDINE COMPOUNDS AND SALTS THEREOF - A compound represented by the formula (I): | 03-17-2011 |
20110086860 | COMPOUND - A compound represented by Formula (I) is provided: | 04-14-2011 |
20110112138 | MULTI-CYCLIC CINNAMIDE DERIVATIVES - The present invention provides a compound represented by the formula (I): | 05-12-2011 |
20140243316 | Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative - A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a therapeutic agent for neurological disorders related to glutamate dysfunction and diseases involving the mGluR2, such as Alzheimer's disease: | 08-28-2014 |